Synapse

← Kwok‐Yung Yuen

Papers by Kwok‐Yung Yuen

Page 2 · newest first

  1. Persistent lung inflammation and alveolar-bronchiolization due to Notch signaling dysregulation in SARS-CoV-2 infected hamster2024
  2. Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoidiScience · 2024
  3. The Emergence of Candida auris is Not Associated with Changes in Antifungal Prescription at HospitalsInfection and Drug Resistance · 2024
  4. Rat hepatitis E virus (Rocahepevirus ratti) exposure in cats and dogs, Hong KongEmerging Microbes & Infections · 2024
  5. Development and Evaluation of an In-House Real-Time RT-PCR Targeting nsp10 Gene for SARS-CoV-2 DetectionInternational Journal of Molecular Sciences · 2024
  6. Disseminated Mycobacterium haemophilum infection in an immunocompromised host: A complex case with immune reconstitution inflammatory syndrome (IRIS) manifestation2024
  7. Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Mycoplasma pneumoniae Infection: A Descriptive StudyAntibiotics · 2024
  8. PMI-controlled mannose metabolism and glycosylation determines tissue tolerance and virus fitnessNature Communications · 2024
  9. Development and Evaluation of an In-House Real-Time Rt-Pcr Targeting nsp10 Gene for SARS-CoV-2 Detection2024
  10. Engineering a “muco‐trapping” ACE2 ‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID ‐19Bioengineering & Translational Medicine · 2024
  11. Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tractEBioMedicine · 2023
  12. Clinical Validation of a Novel Point of Care Mp1p Antigen Lateral Flow Immunoassay to Diagnose Talaromyces marneffei InfectionOpen Forum Infectious Diseases · 2023
  13. Development of Interferon-Gamma Release Assays for Diagnosing Latent TalaromycosisOpen Forum Infectious Diseases · 2023
  14. An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal modelsNature Communications · 2023
  15. Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational lockingImmunity · 2023
  16. An RNA-Scaffold Protein Subunit Vaccine for Nasal ImmunizationVaccines · 2023
  17. Prevalence and Characteristics of Invasive Staphylococcus argenteus among Patients with Bacteremia in Hong KongMicroorganisms · 2023
  18. An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variantsNature Communications · 2023
  19. The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5EBioMedicine · 2023
  20. SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters 1Emerging Microbes & Infections · 2023
  21. Rational design of a booster vaccine against COVID-19 based on antigenic distanceCell Host & Microbe · 2023
  22. Preparation for the next pandemic: challenges in strengthening surveillanceEmerging Microbes & Infections · 2023
  23. A Pilot Study of Short-Course Oral Vitamin A and Aerosolised Diffuser Olfactory Training for the Treatment of Smell Loss in Long COVIDBrain Sciences · 2023
  24. An immunoassay system to investigate epidemiology of Rocahepevirus ratti (rat hepatitis E virus) infection in humansJHEP Reports · 2023
  25. Epidemiology of multidrug-resistant organisms before and during COVID-19 in Hong KongInfection Prevention in Practice · 2023
  26. Whipple’s disease presenting as weight gain and constipation in a Chinese womanBMC Infectious Diseases · 2023
  27. Cutaneous Mycobacterium szulgai infection in a patient with Cushing's syndrome: a case report and literature reviewBMC Infectious Diseases · 2023
  28. Intranasal infection by SARS-CoV-2 Omicron variants can induce inflammatory brain damage in newly weaned hamstersEmerging Microbes & Infections · 2023
  29. Genomic bacterial load associated with bacterial genotypes and clinical characteristics in patients with scrub typhus in Hainan Island, Southern ChinaPLoS neglected tropical diseases · 2023
  30. Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variantsProceedings of the National Academy of Sciences · 2023
  31. An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamstersSHILAP Revista de lepidopterología · 2023
  32. Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking2023
  33. Tailoring combinational therapy with Monte Carlo method-based regression modelingFundamental Research · 2023
  34. A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy AdultsVaccines · 2023
  35. Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of MiceViruses · 2023
  36. COVID-19 mRNA vaccine protects against SARS-CoV-2 Omicron BA.1 infection in diet-induced obese mice through boosting host innate antiviral responsesEBioMedicine · 2023
  37. Positive‐strand RNA viruses—a Keystone Symposia reportAnnals of the New York Academy of Sciences · 2023
  38. Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional studyEBioMedicine · 2023
  39. Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong KongThe Lancet Regional Health - Western Pacific · 2022
  40. Analogous comparison unravels heightened antiviral defense and boosted viral infection upon immunosuppression in bat organoidsSignal Transduction and Targeted Therapy · 2022
  41. Correlations of Myeloperoxidase (MPO), Adenosine deaminase (ADA), C–C motif chemokine 22 (CCL22), Tumour necrosis factor alpha (TNFα) and Interleukin-6 (IL-6) mRNA expression in the nasopharyngeal specimens with the diagnosis and severity of SARS-CoV-2 infectionsEmerging Microbes & Infections · 2022
  42. Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccinesThe Lancet Microbe · 2022
  43. Infection of healthcare workers despite a high vaccination rate during the fifth wave of COVID-19 due to Omicron variant in Hong KongSHILAP Revista de lepidopterología · 2022
  44. Development and Validation of a Novel COVID-19 nsp8 One-Tube RT-LAMP-CRISPR Assay for SARS-CoV-2 DiagnosisMicrobiology Spectrum · 2022
  45. Evolution and Control of COVID-19 Epidemic in Hong KongViruses · 2022
  46. Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2Emerging Microbes & Infections · 2022
  47. The first case of monkeypox in Hong Kong presenting as infectious mononucleosis-like syndromeEmerging Microbes & Infections · 2022
  48. An IgM-like Inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-22022
  49. Air dispersal of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Implications for hospital infection control during the fifth wave of coronavirus disease 2019 (COVID-19) due to the SARS-CoV-2 omicron variant in Hong KongInfection Control and Hospital Epidemiology · 2022
  50. A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivoCell Reports Medicine · 2022